# Opposing Step-by-step Insulin Reinforcement to Intensified Strategy

> **NCT00174642** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 811 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glargine
- **DRUG:** Insulin Glulisine
- **DRUG:** Metformin
- **DRUG:** insulin secretagogue

## Key facts

- **NCT ID:** NCT00174642
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-12
- **Final completion:** —
- **Target enrollment:** 811 (ACTUAL)
- **Last updated:** 2009-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174642, "Opposing Step-by-step Insulin Reinforcement to Intensified Strategy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00174642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*